Neuropeptides
Volume 44, Issue 5 , Pages 431-435 , October 2010

Serum hepatocyte growth factor levels and the effects of antidepressants in panic disorder

Received 30 January 2010 ,Accepted 27 April 2010.

References 

  1. Achim CL, Katyal S, Wiley CA, Shiratori M, Wang G, Oshika E, et al. Expression of HGF and c-Met in the developing and adult brain. Developmental Brain Research. 1997;102:299–303
  2. Aoki M, Morishita R, Taniyama Y, Kida I, Moriguchi A, Matsumoto K, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infracted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Therapy. 2000;7:417–427
  3. Ban Y, Watanabe T, Miyazaki A, Nakano Y, Tobe T, Idei T, et al. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis. 2006;195:153–159
  4. De Frances M, Wolf H, Michalopoulos GK, Zarnegar R. The presence of hepatocyte growth factor in the developing rat. Development. 1992;116:387–395
  5. Di Renzo MF, Bertolotto A, Olivero M, Crepaldi T, Pagni CA, Comoglio PM. Selective expression of themet HGF receptor in human central nervous system microglia. Oncogene. 1993;8:219–222
  6. Ebens A, Brose K, Leonardo ED, Hanson MG, JrBladt F, Birchmeier C, et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motorneurons. Neuron. 1996;17:1157–1172
  7. Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene. 2000;19:5582–5589
  8. Gordon MS, Sweeney CS, Mendelson DS, Eckhardt SG, Anderson A, Beaupre DM, et al. Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors. Clinical Cancer Research. 2010;16:699–710
  9. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. Journal of Neuroscience Research. 1996;43:554–564
  10. Hayashi, S., Morishita, R., Nakamura, S., Yamamoto, K., Moriguchi, A., Nagano, T., Taizi, M., Noguchi, H., Matsumoto, K., Nakamura, T., Higaki, J., Ogihara, T., 1999. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: down-regulation of HGF in response to hypoxia in vascular cells. Circulation 100, II301–II308.
  11. Hayashi K, Morishita R, Nakagami H, Yoshimura S, Hara A, Matsumoto K, et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Therapy. 2001;8:1167–1173
  12. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, Nakamura T. Localization and functional coupling of HGF and c-Met/HGF receptor in rat brain: implication as neurotrophic factor. Molecular Brain Research. 1995;32:197–210
  13. Isogawa K, Akiyoshi J, Kodama K, Matsushita H, Tsutsumi T, Funakoshi H, et al. Anxiolytic effect of hepatocyte growth factor infused into rat brain. Neuropsychobiology. 2005;51:34–38
  14. Jenkins TA, Chai SY. Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats. Neurobiology of Learning and Memory. 2007;87:218–224
  15. Jung W, Castrén E, Odenthal M, Vande Woude G, Dienes HP, Lindholm D, et al. Expression and functional interaction of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor c-Met in mammalian brain. Journal of Cell Biology. 1994;126:485–494
  16. Korhonen L, Sjoholm U, Takei N, Kern MA, Schirmacher P, Castren E, et al. Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. European Journal of Neuroscience. 2000;12:3453–3461
  17. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, et al. The MINI international neuropsychiatric interview (M.I.N.I.) a short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry. 1997;12:224–231
  18. Levitt P. Disruption of interneuron development. Epilepsia. 2005;46(Suppl. 7):22–28
  19. Ma PC, Maulik G, Ghristensen J, Salgia R. C-Met: structure, functions and potential for therapeutic inhibition. Cancer and Metastasis Reviews. 2003;22:309–325
  20. Maina F, Hilton MC, Ponzetto C, Davies AM, Klein R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes and Development. 1997;11:3341–3350
  21. Maina F, Hilton MC, Andres R, Wyatt S, Klein R, Davies AM. Multiple roles for hepatocyte growth factor in sympathetic neuron development. Neuron. 1998;20:835–846
  22. Miyazawa T, Matsumoto K, Ohmichi H, Katoh H, Yamashima T, Nakamura T. Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. Journal of Cerebral Blood Flow and Metabolism. 1998;18:345–348
  23. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as ‘‘cytokine supplement therapy’’. Hypertension. 1999;33:1379–1384
  24. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440–443
  25. Pan W, Yu Y, Yemane R, Cain C, Yu C, Kastin AJ. Permeation of hepatocyte growth factor across the blood–brain barrier. Experimental Neurology. 2006;201:99–104
  26. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude GF. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proceedings of the National Academy of Sciences USA. 1987;84:6379–6383
  27. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. Journal of Neuroscience. 2003;23:622–631
  28. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonora LI, et al. Reliability and validity of the MINI international neuropsychiatric interview (M.I.N.I.): according to the SCID-P. European Psychiatry. 1997;12:232–241
  29. Streit A, Stern CD, Thery C, Ireland GW, Aparicio S, Sharpe MJ, et al. A role for HGF/SF in neural induction and its expression in Hensen’s node during gastrulation. Development. 1995;121:813–824
  30. Tashiro K, Hagiya M, Nishizawa T, Sekim T, Shimonishi M, Shimizu S, et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proceeding of the National Academy of Sciences USA. 1990;87:3200–3204
  31. Tsuboi Y, Kakimoto K, Nakajima M, Akatsu H, Yamamoto T, Ogawa K, et al. Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer’s disease. Acta Neurologica Scandinavica. 2003;107:81–86
  32. Wakatsuki M, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Matsushita H, et al. Administration of antisense DNA for hepatocyte growth factor causes an depressive and anxiogenic response in rats. Neuropeptides. 2007;41:477–483
  33. Watanabe T, Yamamoto H, Idei T, Iguchi T, Katagiri T. Influence of insulin-like growth factor-1 and hepatocyte growth factor on carotid atherosclerosis and cognitive function in the elderly. Dement and Geriatric Cognitive Disorders. 2004;18:67–74
  34. Wong V, Glass DJ, Arriaga R, Yancopoulos GD, Lindsay RM, Conn G. Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor. Journal of Biological Chemistry. 1997;272:5187–5191
  35. Wright JW, Yamamoto BJ, Harding JW. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Progress in Neurobiology. 2008;84:157–181
  36. Yamada K, Moriguchi A, Morishita R, Aoki M, Nakamura Y, Mikami H, et al. Efficient oligonucleotide delivery using the HVJ liposome method in the central nervous system. American Journal of Physiology. 1996;271:R1212–R1220
  37. Yamamoto Y, Livet J, Pollock RA, Garces A, de Arce V, Lapeyriére O, et al. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development. 1997;124:2903–2913
  38. Zarnegar R, Michalopoulos G. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. Journal of Cell Biology. 1995;129:1177–1180

PII: S0143-4179(10)00048-X

doi: 10.1016/j.npep.2010.04.007

Neuropeptides
Volume 44, Issue 5 , Pages 431-435 , October 2010

Article Tools

* Image Usage & Resolution